<?xml version="1.0" encoding="UTF-8"?><marc:collection xmlns:marc="http://www.loc.gov/MARC21/slim">
  <marc:record>
    <marc:leader>00000nam  2200000zi 4500</marc:leader>
    <marc:controlfield tag="001">9.895466</marc:controlfield>
    <marc:controlfield tag="003">CaOODSP</marc:controlfield>
    <marc:controlfield tag="005">20221107174032</marc:controlfield>
    <marc:controlfield tag="007">cr |n|||||||||</marc:controlfield>
    <marc:controlfield tag="008">210119e199109  onco    o    f000 0 eng d</marc:controlfield>
    <marc:datafield tag="040" ind1=" " ind2=" ">
      <marc:subfield code="a">CaOODSP</marc:subfield>
      <marc:subfield code="b">eng</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="043" ind1=" " ind2=" ">
      <marc:subfield code="a">n-cn---</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="086" ind1=" " ind2=" ">
      <marc:subfield code="a">Z1-1989/3-11-1E-PDF</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="110" ind1="1" ind2=" ">
      <marc:subfield code="a">Canada.</marc:subfield>
      <marc:subfield code="b">Royal Commission on New Reproductive Technologies, </marc:subfield>
      <marc:subfield code="e">author. </marc:subfield>
      <marc:subfield code="e">issuing body.</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="245" ind1="1" ind2="0">
      <marc:subfield code="a">What we heard : </marc:subfield>
      <marc:subfield code="b">issues and questions raised during the public hearings.</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="264" ind1=" " ind2="1">
      <marc:subfield code="a">Ottawa, Ontario : </marc:subfield>
      <marc:subfield code="b">Royal Commission on New Reproductive Technologies = Commission royale sur les nouvelles techniques de reproduction, </marc:subfield>
      <marc:subfield code="c">September 1991.</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="300" ind1=" " ind2=" ">
      <marc:subfield code="a">1 online resource (44 pages) : </marc:subfield>
      <marc:subfield code="b">photographs</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="336" ind1=" " ind2=" ">
      <marc:subfield code="a">text</marc:subfield>
      <marc:subfield code="b">txt</marc:subfield>
      <marc:subfield code="2">rdacontent</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="337" ind1=" " ind2=" ">
      <marc:subfield code="a">computer</marc:subfield>
      <marc:subfield code="b">c</marc:subfield>
      <marc:subfield code="2">rdamedia</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="338" ind1=" " ind2=" ">
      <marc:subfield code="a">online resource</marc:subfield>
      <marc:subfield code="b">cr</marc:subfield>
      <marc:subfield code="2">rdacarrier</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="500" ind1=" " ind2=" ">
      <marc:subfield code="a">Digitized edition from print [produced by Privy Council Canada].</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="500" ind1=" " ind2=" ">
      <marc:subfield code="a">Issued also in French under title: Les audiences publiques : témoignages et opinions.</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="505" ind1="0" ind2=" ">
      <marc:subfield code="a">Message from the Chairperson of the Royal Commission on New Reproductive Technologies -- Introduction -- What we heard during the public hearings -- How do people in Canada view fertility? -- What do people think about the technologies and their implications? -- What impact do new reproductive technologies have on various groups in Canadian society? -- What should Canadian society do about new reproductive technologies? -- Submitting your views to the Royal Commission -- Appendices.</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="520" ind1=" " ind2=" ">
      <marc:subfield code="a">"The Commission has produced this summary of issues and questions to inform people in Canada about what we heard. We hope it will encourage input from individuals and organizations who have not yet participated in our work"--Message from the Chairperson of the Royal Commission on New Reproductive Technologies, page 6.</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="530" ind1=" " ind2=" ">
      <marc:subfield code="a">Issued also in printed form.</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="650" ind1=" " ind2="0">
      <marc:subfield code="a">Human reproductive technology</marc:subfield>
      <marc:subfield code="x">Social aspects</marc:subfield>
      <marc:subfield code="z">Canada.</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="650" ind1=" " ind2="0">
      <marc:subfield code="a">Human reproductive technology</marc:subfield>
      <marc:subfield code="x">Moral and ethical aspects</marc:subfield>
      <marc:subfield code="z">Canada.</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="775" ind1="0" ind2="8">
      <marc:subfield code="t">Les audiences publiques : </marc:subfield>
      <marc:subfield code="w">(CaOODSP)9.895469</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="776" ind1="0" ind2="#">
      <marc:subfield code="t">What we heard : </marc:subfield>
      <marc:subfield code="w">(CaOODSP)9.645310</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="856" ind1="4" ind2="0">
      <marc:subfield code="q">PDF</marc:subfield>
      <marc:subfield code="s">23.62 MB</marc:subfield>
      <marc:subfield code="u">https://publications.gc.ca/collections/collection_2021/bcp-pco/Z1-1989-3/Z1-1989-3-11-1-eng.pdf</marc:subfield>
    </marc:datafield>
  </marc:record>
</marc:collection>
